Clinical trial Recruiting at 1 site Observational Ages 18 and up

Treatment for coronary artery disease using drug-coated balloons

Official title: Drug-coating Balloon Treatment in Coronary Artery Disease: a Prospective, Multicenter, Registry Study (ULTIMATE-DCB)

Run by Nanjing First Hospital, Nanjing Medical University · NCT04255563 · Data updated 2026-11-12

This study is testing how well drug-coated balloons work for treating people with coronary artery disease and checking if they are safe to use.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment3000 (estimated)
SponsorNanjing First Hospital, Nanjing Medical University
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedFebruary 25, 2020
Main results expectedDecember 30, 2030
Study endsDecember 30, 2030
Registry record updatedNovember 15, 2024
Trial IDNCT04255563 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with coronary artery disease who are suitable for drug-coated balloon treatment.

Probably not a fit

Patients who are pregnant, have contraindications to contrast media or antiplatelet therapy, or are in cardiac shock may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the efficacy and safety of drug-coated balloon (DCB) treatment in patients with coronary artery disease (CAD). It is a prospective, multi-center registry that enrolls patients undergoing DCB treatment without strict inclusion and exclusion criteria. Data and images will be collected during the procedure and at follow-up visits to assess outcomes.

Why it matters

Potential benefit: If successful, this treatment could provide a less invasive option for managing coronary artery disease, potentially improving patient outcomes.

How similar studies have gone: Other studies have shown promising results with drug-coated balloon treatments in similar patient populations, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients suitable for DCB treatment

Exclusion Criteria:

* Pregnancy
* Contraindications to contrast media, antiplatelet therapy, or paclitaxel
* Expected life less than 12 months
* Cardiac shock

Where it's running

  • Nanjing First Hospital
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.